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ABSTRACT  
Introduction: In some young female candidates of assisted reproductive technology (ART), 
ovarian response to simulative treatments is less than what is expected. More precise assess-
ment of oocyte quality and quantity through studying ovarian dimensions can be useful for 
determining the dose of ovarian stimulant drugs and for preventing ART cycles cancellation. 
The aim of the present study is to determine the association between ovarian dimensions and 
ovarian reserve (OR) indices and whether ovarian dimensions can predict ovarian reserve.  
Methods: In this cross-sectional study, 85 infertile women were studied. In early follicular 
phase, ovarian diameters (including length and width of the ovaries) were measured using 
transvaginal ultrasonography. Mean ovarian diameters (MOD) were calculated according to 
average length and width of the ovaries. A serum sample was taken from all patients to meas-
ure the level of Follicular Stimulating Hormone (FSH) and oestradiol as OR indices. 
Results: The results of univariate analysis showed that FSH and oestradiol had a negative sig-
nificant association with width, length and MOD (P < 0.01). The results of multivariate re-
gression analysis showed that FSH and oestradiol had a negative significant association with 
width (βFSH = -0.59,P = 0.001 and βOestradiol = -0.019,P = 0.029) and MOD (βFSH = -
0.52,P = 0.003 and βOestradiol = -0.021,P = 0.017) and had a borderline negative significant cor-
relation with ovarian length (βFSH = -0.49,P=0.077 and βOestradiol = 0.022,P = 0.08) 
Conclusions: The results of this study revealed that despite a moderate correlation, ovarian di-
ameters could be an applicable index for predicting OR. Using this method along with other 
methods may be useful in treatment with ovarian stimulants. 
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INTRODUCTION 
About 10-15 % of reproductive-age 
couples suffer from infertility. Ovarian sti-
mulation is one of the fundamental prelimi-
nary steps of assisted reproductive technol-
ogy (ART) (Berek, 2007; Fritz and Speroff, 
2011). The evaluation of ovarian reserve 
(OR) may help predict women who proba-
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bly under-respond or over-respond to con-
trolled ovarian hyperstimulation protocols 
in ART programs (Bukulmez and Arici, 
2004; Vladimirov et al., 2005; Bancsi et al., 
2002; Chang et al., 1998; La Marca et al., 
2012). 
OR is defined as the number and quality 
of the recruited follicles remained in the 
ovary at all ages (Broekmans et al., 2006; 
Coccia and Rizzello, 2008). A precise and 
valid measure of the quantitative OR con-
sistes of the enumeration of total follicles 
that existing both ovaries (Block, 1952). 
Pregnancy likelihood in infertility therapy 
such as intra-uterine insemination (IUI) and 
in-vitro fertilization (IVF), or in the follow-
up of spouses within and then the initial in-
fertility work-up are proxy variables for oo-
cyte quality which are currently applied 
(Broekmans et al., 2006). According to the 
ESHRE working group following a consen-
sus, poor ovarian responders (POR) are 
specified when at least two of the follow-
ings are met: 
1) high maternal age or presence of other 
potential risk factors of POR, 
2) previous history of POR,  
3) Abnormal ovarian reserve test (ORT) 
(Ferraretti et al., 2011). 
Follicular stimulating hormone(FSH) is 
the most commonly used test to assess OR. 
Third day of cycle is the best testing day 
because the expected low level of oestradiol 
affects FSH levels related to a negative 
feedback control (Perloe et la., 2000; Rou-
debush et al., 2008). Day-3 FSH and oes-
tradiol are both measured typically (Sharara 
and McClamrock, 1999; Toner, 2003; Barn-
hart and Osheroff, 1998). However, other 
blood tests like antimullerian hormone 
(AMH) and inhibin-B have become popular 
recently because they determine ovarian 
status more directly; day-3 FSH and oestra-
diol are indirect measurements (Dehghani-
Firouzabadi et al., 2008; Jayaprakasan et 
al., 2010; Ebner et al., 2006; La Marca et 
al., 2007; Feyereisen et al., 2006; Visser et 
al., 2006). 
Making use of ovarian dimensions - as 
criteria to evaluate OR and to predict ovari-
an response to stimulative treatments - has 
been investigated in a few studies (Frat-
tarelli et al., 2000; 2002; Bowen et al., 
2007). A study carried out by Frattarelli et 
al. (2000) on 278 infertile female candi-
dates of IVF showed that a significant asso-
ciation was found between MOD (which 
calculated as the sum of ovarian length and 
ovarian width divided by two) and age, se-
rum FSH and FSH:LH ratio after some co-
founder factors such as smoking and body 
mass index (BMI) were controlled. In a re-
cent study by Bowen et al. (2007) on 69 re-
productive-age patients, a significant nega-
tive correlation was found between all ovar-
ian diameters (including width, length and 
mean ovarian diameters) and serum FSH 
and age. Ovarian width was recognized as 
the strongest predictor of ovarian reserve 
but this study did not examine the associa-
tion between ovarian dimensions and serum 
oestradiol (Bowen et al., 2007). 
The present study aimed to determine 
the association between width, length and 
mean ovarian dimensions with OR indices 
including FSH and serum Oestradiol. Like-
wise, we aimed to show whether ovarian di-
mensions can be a good or reliable predic-
tor for ovarian reserve.  
 
METHODS 
Participants 
The study population consisted of 85 in-
fertile women who referred to IVF unit of 
Mirza Koochak Khan Hospital (which is 
one of the teaching hospitals affiliated to 
Tehran University of Medical Sciences 
(TUMS)) from July 2009 to April 2010. 
These subjects were randomly selected to 
participate in this study. Women aged more 
than 44 and those who had a history of pre-
vious unilateral oophorectomy, were ex-
cluded. This study was approved by ethics 
committee of TUMS. A written informed 
consent was obtained from all patients who 
participated in the study. 
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Ovarian reserve (OR) measurements  
Serum samples were taken in the first to 
third day of menstruation and FSH and se-
rum oestradiol levels were measured [ELI-
SA, Roche Elecsys1010, Roche Diagnos-
tics, Indianapolis; Oestradiol II, minimal 
detection limit 5pg/ml, intra-assayCV 5.7 % 
and inter-assay CV 6.2 % and FSH, mini-
mal detection limit 0.10 mIU/ml, intra-as-
say CV 1.8 % and inter-assay CV 5.3 %.]. 
Serum sampling was done at the same day 
when ultrasonographic measurement was 
taken. The results were calculated with an 
automated method using a 4 PL (4 Parame-
ter Logistics) curve fit. 
 
Ovarian dimensions measurements  
To avoid the reproducibility within and 
between observers, transvaginal ultrasonog-
raphy was done only by one infertility fel-
lowship. 7-MHz frequency of Medison ul-
trasound machine was used, and both length 
and width of every ovary were measured in 
millimeter in the biggest sagittal plan. The 
variable “ovarian length” was calculated as 
“the sum of right ovarian length and left 
ovarian length divided by two” and the var-
iable “ovarian width” as “the sum of right 
ovarian width and left ovarian width divid-
ed by two”. Patients’ weight (kg) and 
height (m) were measured and their BMI 
was calculated as subjects’ weight (in kg) 
divided by height (in m) squared. All pa-
tients were asked verbally about their ciga-
rette smoking. The cause of infertility was 
extracted from the patient’s recorded files. 
 
Sample size and statistical analysis 
The sample size was determined using 
correlation formula (N = ((Z1-α/2+ Z1-β)2 × 
(1-r2))/(r2)). Where r, based on the data on 
Bowen et al. (2007) study, as the correla-
tion between increasing levels of FSH and a 
significant decrease in the mean ovarian di-
ameters, was equal to -0.3 and type I error 
(α) and the statistical power (1-β) were 5 % 
and 80 %, respectively. Allowing for a 5 % 
dropout rate, the study required 85 subjects. 
Data were presented as mean and stand-
ard deviation (SD) for continuous variables 
and relative and absolute frequencies for 
categorical variables. Pearson Correlation 
(r) was used to determine the strength of the 
correlation between mean ovarian diameter 
and variables including FSH, oestradiol and 
age. To predict the ovarian reserve indices 
(FSH, oestradiol) using the ovarian dimen-
sions parameters (length, width and mean 
ovarian dimensions), a univariate linear re-
gression analysis was used. For each ovari-
an dimension, a linear regression was per-
formed to fit concerning models and regres-
sion coefficients or Beta coefficients (β) 
were reported. The interpretation of these 
beta coefficients is how much are the de-
pendent variables (such as width, length 
and mean ovarian dimension here) expected 
to change (decrease or increase) for one-
unit change in independent variables (such 
as FSH and oestradiol here). To control the 
effects of some potential confounder varia-
bles such as age, smoking and BMI, a mul-
tivariate linear regression analysis was 
used. To determine the accuracy of the re-
gression models, coefficients of determina-
tion (R2) were calculated and reported. This 
value (R2) shows an insight into the “good-
ness of fit” of the statistical model, linear 
regression models in this study. This coeffi-
cient is valued between 0 and 1. R2 equal to 
1 indicates that the models perfectly fit the 
data and R2 equal to 0 indicates that the fit-
ted model does not explain variations at all. 
All statistical analysis was done using SPSS 
version 15 for windows software and 
STATA version 10. P < 0.05 was consid-
ered statistically significant. 
 
RESULTS 
85 patients were recruited in the study 
over the study period. The mean age of all 
subjects was 32.2 ± 6.1 years. Table 1 
shows the subjects’ descriptive information. 
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The mean serum FSH and oestradiol 
levels were 7.3 ± 3.5 ml U/ml and 
72.4 ± 66.9 pg/ml, respectively. The most 
common causes of infertility were male-
factor, tubal-factor, diminished OR and 
PCOD with frequency of 29.5, 16.5, 16.5 
and 12.5 %, respectively. Table 1 lists other 
main causes regarded to the study popula-
tion. The mean ovarian length and width 
were 45 ± 8.5 mm and 29 ± 5.6 mm, re-
spectively. Nearly 5 % of patients were 
smokers.  
 
The association between ovarian width 
and OR indices 
Univariate linear regression analysis 
showed that FSH, oestradiol and age had a 
significant linear association with ovarian 
width. Beta coefficients of linear regression 
for these three variables were -0.75, -0.028 
and -0.35mm, respectively (P < 0.05). The 
highest level of coefficient of determination 
was 0.20 for FSH index (meaning, 20 % of 
variations of ovarian width were explained 
by FSH). 
After confounder factors including age, 
cigarette smoking and BMI were con-
trolled, multivariate linear regression analy-
sis revealed that FSH and oestradiol had a 
significant negative association with ovari-
an width. Coefficient of determination (R2) 
for FSH increased from 0.20 to 0.23 and for 
oestradiol from 0.10 to 0.16 (Table 2). 
 
The association between ovarian length 
and OR indices 
Results of univariate linear regression 
analysis showed that FSH, oestradiol and 
age had a significant negative association 
with ovarian length. Beta coefficients of 
linear regression for these three variables 
were -0.87, -0.035 and -0.65mm, respec-
tively (P < 0.05). The coefficient of deter-
mination for FSH was 0.12, (meaning, 
12 % of variations of ovarian length were 
explained by FSH).  
 
 
 
Table 1: Descriptive characteristics and main causes of infertility of study sample 
Variables  Descriptive statistics 
Age (years) 32.38 ± 6.1 (19-43) 
BMI (kg/m2) 23.8 ± 3.1 (18-33) 
FSH (mIU/ml) 7.3 ± 3.5 (2-18/7) 
Oestradiol (pg/ml)* 72.4 ± 66.9 (12-463) 
Ovarian length (mm)* 45 ± 8.5 (29-69) 
Ovarian width(mm)* 29 ± 5.6 (9-42) 
Overall Ovarian Diameter (mm)* 37 ± 6 (20-54) 
Infertility reasons (No., %)** 
Diminished OR 14 (16.5) 
Male factor 25 (29.5) 
Tubal factor 14 (16.5) 
PCOD  11 (12.5) 
Unexplained 8 (9.5) 
Endometriosis 8 (9.5) 
Multifactorial 5 (5.9) 
*data are presented as: mean ± SD (min-max), ** N (%)\ 
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Table 2: Univariate and multivariate linear regression of Follicular Stimulating Hormone (FSH) and 
oestradiol on ovarian length, ovarian width and overall ovarian mean 
 Univariate model  Multivariate model ¥ 
Width β crude  P value R2  β Adjusted  P value R2 
FSH -0.75 < 0.001 0.20 -0.59 0.001 0.23 
Oestradiol -0.028 0.002 0.10 -0.019 0.029 0.16 
Age  -0.35 < 0.001 0.15 - - - 
        
Length 
FSH -0.87 0.001 0.12 -0.46 0.077 0.23 
Oestradiol -0.038 0.005 0.089 -0.022 0.08 0.23 
Age  -0.65 < 0.001 0.22 - - - 
        
Overall Ovarian Mean 
FSH -0.81 < 0.001 0.19 -0.52 0.003 0.32 
Oestradiol -0.033 0.001 0.13 -0.021 0.017 0.29 
Age  -0.50 < 0.001 0.26 - - - 
¥: adjusted for age, smoking status and BMI 
 
 
Results of multivariate linear regression 
analysis showed that FSH and oestradiol 
had a borderline significant negative asso-
ciation with ovarian length. R2 for FSH and 
oestradiolin multivariate analysis increased 
from 0.12 to 0.23 and from 0.08 to 0.23, re-
spectively (Table 2).  
 
The relationship between mean ovarian 
diameter and OR indices 
The Pearson correlation showed a sig-
nificant negative correlation between mean 
ovarian diameter and FSH (r = -45, 
P < 0.001), oestradiol (r = -0.36, P = 0.001) 
and age (r = -0.52, P  < 0.001) (Figure 1, 2, 
3). According to results of the univariate 
linear regression analysis, FSH, oestradiol 
and age had a significant negative associa-
tion with mean ovarian diameters (MOD). 
Beta coefficients of linear regression for 
these three variables were -0.81, -0.033 and 
-0.50 mm, respectively (P < 0.05). The co-
efficient of determination (R2) for FSH, 
oestradiol and age was obtained as 0.19, 
0.13 and 0.26, respectively. 
Results of multivariate linear regression 
analysis revealed that, FSH and oestradiol 
still had a significant reverse association 
with ovarian length (P < 0.05). R2 for FSH 
and oestradiol increased from 0.19 to 0.32 
and from 0.13 to 0.29, respectively (Table 
2). 
 
DISCUSSION 
Results showed that ovarian measure-
ments had a strong and significant relation-
ship with biological indices of ovarian re-
serve like FSH and serum oestradiol as well 
as patients’age. Results also revealed that 
by adjusting effects of some confounder 
variables like smoking, BMI and age, still a 
significant relationship can be observed be-
tween ovarian reserve and ovarian dimen-
sions. The highest level of changes factor 
was related to FSH, that justified more than 
20 % of changes of all three ovarian dimen-
sions in the adjusted model. 
Several research has been carried out so 
far to discover a useful index for determin-
ing ovarian reserve. Ultrasonography can 
be a useful tool to determine ovarian per-
formance. In a prospective study by Adibi 
et al. (2012) on fifty two women (aged 18-
46) with regular cycles, antral follicles 
count (AFC) was considered a better  
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Figure 1: Pearson correlation (r) between 
mean ovarian diameters and Follicular Stimulat-
ing Hormone (R square: coefficients of determi-
nation) 
 
 
Figure 2: Pearson correlation (r) between 
mean ovarian diameters and Oestradiol (R 
square: coefficients of determination) 
 
 
Figure 3: Pearson correlation (r) between 
mean ovarian diameters and age (R square: 
coefficients of determination) 
method for predicting ovarian response to 
ovulation induction protocol compared with 
ovarian volume and hormonal tests. In an-
other recent study conducted by Kelsey et 
al. (2012) there was a strong and positive 
correlation (r = 0.89-0.99 based on different 
statistical models) between ovarian volume 
and the number of non-growing follicles 
(NGFs) in the human ovary aged 25-51. 
According to these results, these research-
ers indicated that ovarian volume - as a sur-
rogate measure- could be a useful indirect 
factor (index) for predicting human ovarian 
reserve for the individual woman (Kelsey et 
al., 2012). However, AFC is a subjective 
matter; in order for it to be a reliable marker 
of ovarian reserve, it needs a high-resolu-
tion machine and a report by the same ob-
server. Furthermore, AFC & ovarian vol-
ume vary in different cycles. Thus, low 
AFC in a regularly-menstruating young wo-
man with ovulation can not predict poor 
ovarian reserve (Roudebush et al., 2008). 
Ovarian stromal blood flow velocity is 
one of the useful indices to predict ovarian 
responsiveness to stimulative treatments; 
however, results do not always correlate 
with advancing age. Likewise, it is not ap-
plicable in all infertility centers due to the 
need for doppler Ultrasonography (Roude-
bush et al., 2008). 
In a recent study by Satwik et al. 
(2012), among FSH, AMH and age, AMH 
was the best factor to predict the overall 
ovarian response and poor response to ovu-
lation induction. The outcome measure was 
the number of oocytes retrieved. Although 
2 pmol/l seemed to be a reasonable cut-off 
of AMH levels for predicting poor re-
sponse, there was an enormous overlap be-
tween average and poor responders in the 
AMH range of 2–10 pmol/l; however, it 
cannot be a definite predictor of non-res-
ponder status (Satwik et al., 2012). 
In our study, ovarian dimensions were 
measured using transvaginal ultrasonogra-
phy. Results showed that all parameters of 
ovarian dimensions including length, width 
and mean ovarian diameter were related to 
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ovarian reserve indices including serum 
FSH and age of patients. Our study was a 
controlled research concerning devastating 
variables including smoking status and 
BMI. 
In a study carried out by Frattarelli et al. 
(2000) in 1999 on 60 patients, the relation-
ship between mean ovarian diameter and 
mean ovarian volume was examined in in-
fertile women who had undergone ART. 
Results showed that more than 90 % of cor-
relation was observed between these two 
mentioned variables. In another study by 
Frattarelli et al. (2002), results of transvagi-
nal Ultrasonography were studied on 278 
patients in follicular phase. Ovarian size 
calculated as average length and width 
showed a significant relationship between 
age, serum FSH and ratio of FSH to LH. In 
this study, confounding factors like smok-
ing and BMI were ignored. 
In another research conducted by Bow-
en et al. in 2007, 69 patients were studied at 
thier pregnancy ages. A significant correla-
tion was found between all ovarian meas-
urements and serum FSH and age; ovarian 
width was the strongest predictor of ovarian 
reserve. The relationship between ovarian 
dimensions and serum oestradiol wasn’t ex-
amined in this study. In our extensive litera-
ture review, we couldn’t find any studies 
that had compared or assessed the relation-
ship between other markers of ovarian re-
serve such as AFC or AMH and ovarian di-
mensions. 
In our study, the highest relationship 
with serum FSH was related to ovarian 
width and ovarian mean; the highest rela-
tionship with serum oestradiol and age was 
related to overall ovarian mean. The differ-
ence between results of our study and those 
of Bowen may be as a result of higher vol-
ume of study or racial differentiation in 
ovarian forms. In both studies, a significant 
relationship was observed between all ovar-
ian dimensions and ovarian reserve indices 
including FSH and age. 
 
Limitations 
The subjects of the study were selected 
using simple random sampling method 
which might influence the generalizability 
of the results of the present study. Likewise, 
our study was carried out only in one hospi-
tal; however, it was a referral hospital in 
our setting (Tehran city), but if we had se-
lected more study population in various in-
fertility centers, results might be more pre-
cise compared to the current findings. An-
other one is that at the time of the study we 
were not able to evaluate AMH of the pa-
tients. Although AMH (rather than FSH) is 
an acceptable measurement to obtain the 
ovarian reserve, we did not have the possi-
bility to compare ovarian dimensions with 
the findings of AMH.  
 
Recommendations 
Further studies are required for the 
proper interpretation of currently applied 
hormonal markers, ultrasound parameters, 
and hormone challenge tests. It seems rea-
sonable to use a combination of these tests 
to improve their predictive value. This ap-
proach may reduce cancelled cycles, waste 
of resources, and emotional stress to the pa-
tient, and it may result in a reasonable preg-
nancy rate. Also, it is recommended to ex-
tend the study to evaluate the ovarian re-
sponse to COH (e.g. number of co-domi-
nant follicle or retrieved oocytes) which has 
been already started by the authors of this 
study 
 
CONCLUSION 
Results of this research revealed that 
ovarian measurements, especially mean 
ovarian diameter, can be an acceptable in-
dex for predicting ovarian reserve; howev-
er, it needs more studies to confirm the re-
sults of our study and similar studies, and it 
needs to compare the results of this method 
with other alternative methods. This know-
ledge may allow physicians to evaluate and 
counsel patients immediately before ART 
stimulation and to optimize stimulation pro-
tocols.  
EXCLI Journal 2013;12:616-624 – ISSN 1611-2156 
Received: May 11, 2013, accepted: June 13, 2013, published: July 04, 2013 
 
 
623 
ACKNOWLEDGEMENTS 
The authors would like to thank the re-
spectable personnel of the IVF ward of the 
Mirza Koochak Khan Hospital for their 
great help in this study. We also thank all 
participants in this study and ethics com-
mittee of Tehran University of Medical 
Sciences.  
 
CONFLICT OF INTEREST 
All authors declare that they have no 
conflict of interest.  
 
REFERENCES 
Adibi A, Mardanian F, Hajiahmadi S. Com-
parison of ovarian volume and antral folli-
cle count with endocrine tests for prediction 
of responsiveness in ovulation induction 
protocols. Adv Biomed Res 2012;1:71 
 
Bancsi LF, Broekmans FJ, Eijkemans MJ, 
de Jong FH, Habbema JD, te Velde ER. 
Predictors of poor ovarian response in in 
vitro fertilization: a prospective study com-
paring basal markers of ovarian reserve. 
Fertil Steril 2002;77:328–36. 
 
Barnhart K, Osheroff J. Follicle stimulating 
hormone as a predictor of fertility. Curr 
Opin Obstet Gynecol 1998;10:227–32. 
 
Berek JS. Infertility. In: Berek and Novak’s 
gynecology (14th ed) (pp 1185-90). Phila-
delphia, PA: Lippincott Williams & Wil-
kins, 2007. 
 
Block E. Quantitative morphological inves-
tigations of the follicular system in women. 
Variations at different ages. Acta Anat (Ba-
sel) 1952;14(Suppl 16):108–23. 
 
Bowen S, Norian J, Santoro N, Pal L. Sim-
ple tools for assessment of ovarian reserve 
(OR): individual ovarian dimensions are re-
liable predictors of OR. Fertil Steril 2007; 
88:390–5. 
 
Broekmans FJ, Kwee J, Hendriks DJ, Mol 
BW, Lambalk CB. A systematic review of 
tests predicting ovarian reserve and IVF 
outcome. Hum Reprod Update 2006;12: 
685-718. 
 
Bukulmez O, Arici A. Assessment of ovari-
an reserve. Curr Opin Obstet Gynecol 2004; 
16:231–7. 
 
Chang MY, Chiang CH, Hsieh TT, Soong 
YK, Hsu KH. Use of the antral follicle 
count to predict the outcome of assisted re-
productive technologies. Fertil Steril 1998; 
69:505–10. 
 
Coccia ME, Rizzello F. Ovarian reserve. 
Ann N Y Acad Sci USA 2008;1127:27–30. 
 
Dehghani-Firouzabadi R, Tayebi N, As-
gharnia M. Serum level of anti-Mullerian 
hormone in early follicular phase as a pre-
dictor of ovarian reserve and pregnancy 
outcome in assisted reproductive technolo-
gy cycles. Arch Iran Med 2008;11:371-6. 
 
Ebner T, Sommergruber M, Moser M, 
Shebl O, Schreier-Lechner E, Tews G. Ba-
sal level of anti-Mullerian hormone is asso-
ciated with oocyte quality in stimulated cy-
cles. Hum Reprod 2006;21:2022–6. 
 
Ferraretti AP, La Marca A, Fauser BC, Tar-
latzis B, Nargund G, Gianaroli L et al. 
ESHRE consensus on the definition of 'poor 
response' to ovarian stimulation for in vitro 
fertilization: the Bologna criteria. Hum Re-
prod 2011;26:1616-24. 
 
Feyereisen E, Mendez Lozano DH, Taieb J, 
Hesters L, Frydman R, Fanchin R. Anti-
Mullerian hormone: clinical insights into a 
promising biomarker of ovarian follicular 
status. Reprod Biomed Online 2006;12: 
695–703. 
 
EXCLI Journal 2013;12:616-624 – ISSN 1611-2156 
Received: May 11, 2013, accepted: June 13, 2013, published: July 04, 2013 
 
 
624 
Frattarelli JL, Lauria-Costa DF, Miller BT, 
Bergh PA, Scott RT. Basal antral follicle 
number and mean ovarian diameter predict 
cycle cancellation and ovarian responsive-
ness in assisted reproductive technology 
cycles. Fertil Steril 2000;74:512–7. 
 
Frattarelli JL, Levi AJ, Miller BT. A pro-
spective novel method of determining ovar-
ian size during in vitro fertilization cycles. J 
Assist Reprod Genet 2002;19:39–41. 
 
Fritz MA, Speroff L. Assisted reproductive 
technologies. In: Clinical gynecologic en-
docrinology and infertility (8th ed) (pp 
1331-40). Philadelphia,, PA: Lippincott 
Williams & Wilkins, 2011. 
 
Jayaprakasan K, Deb S, Batcha M, Hopkis-
son J, Johnson I, Campbell B et al. The co-
hort of antral follicles measuring 2-6 mm 
reflects the quantitative status of ovarian re-
serve as assessed by serum levels of anti-
Müllerian hormone and response to con-
trolled ovarian stimulation. Fertil Steril 
2010;94:1775-81. 
 
Kelsey TW, Wallace WH. Ovarian volume 
correlates strongly with the number of 
nongrowing follicles in the human ovary. 
Obstet Gynecol Int 2012;2012:305025.  
 
La Marca A, Giulini S, Tirelli A, Bertucci 
E, Marsella T, Xella S et al. Anti-Mullerian 
hormone measurement on any day of the 
menstrual cycle strongly predicts ovarian 
response in assisted reproductive technolo-
gy. Hum Reprod 2007;22:766–71. 
 
La Marca A, Argento C, Sighinolfi G, Gris-
endi V, Carbone M, D'Ippolito G et al. Pos-
sibilities and limits of ovarian reserve test-
ing in ART. Curr Pharm Biotechnol 2012; 
13:398-408. 
 
Perloe M, Levy DP, Sills ES. Strategies for 
ascertaining ovarian reserve among women 
suspected of subfertility. Int J Fertil Wom-
ens Med 2000;45:215–24. 
Roudebush WE, Kivens WJ, Mattke JM. 
Biomarkers of ovarian reserve. Biomark In-
sights 2008;3:259-68. 
 
Satwik R, Kochhar M, Gupta SM, Majum-
dar A. Anti-Mullerian hormone cut-off val-
ues for predicting poor ovarian response to 
exogenous ovarian stimulation in in-vitro 
fertilization. J Hum Reprod Sci 2012;5: 
206-12.  
 
Sharara FI, McClamrock HD. The effect of 
aging on ovarian volume measurements in 
infertile women. Obstet Gynecol 1999;94: 
57–60. 
 
Toner JP. Ovarian reserve, female age and 
the chance for successful pregnancy. Mi-
nerva Ginecol 2003;55:399–406. 
 
Visser JA, de Jong FH, Laven JS, Them-
men AP. Anti-Mullerian hormone: a new 
marker for ovarian function. Reproduction 
2006;131:1–9. 
 
Vladimirov IK, Tacheva DM, Kalinov KB, 
Ivanova AV, Blagoeva VD. Prognostic val-
ue of some ovarian reserve tests in poor re-
sponders. Arch Gynecol Obstet 2005;272: 
74–9. 
